Crossmark

Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE

Crossref DOI link: https://doi.org/10.1186/s13550-026-01402-2

Published Online: 2026-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Fei

Yang, Hongxing

Zhang, Jianping

Li, Jindian

Qiao, Ying

Chen, Jie

Song, Shaoli https://orcid.org/0000-0003-2544-7522
Funding

Funding for this research was provided by:

Major Program of National Natural Science Foundation of China (U23A20465)

Shanghai Pujiang Program (22PJ1401700)

Shanghai Science and Technology Commission Project (23DZ2291400)

Shanghai Science and Technology Commission Project (23TS1400800)
License Information

Text and Data Mining valid from 2026-02-25

Version of Record valid from 2026-03-31
More Information

Article History

Received: 7 August 2025

Accepted: 16 February 2026

First Online: 25 February 2026

Declarations

:

: Our study was approved by the Ethics Committee of FUSCC (2210262-2) in accordance with the guidelines of the Declaration of Helsinki and its subsequent amendments. All authors declare that informed consent for SPECT/CT imaging prior to the examination was obtained from all individual participants included in the study.

: Written informed consent for publication was obtained from all study participant.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below